Reliability INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink
Reliability Incorporated reports Q1 2026 revenue growth of 17% and resolves long-standing Vivos Group litigation.
OTC.Pink
Reliability Incorporated reported a significant revenue decline and increased net losses in Q3 2025, primarily due to its EOR segment, while actively pursuing an $8.65 million arbitration award against the Vivos Group.
OTC.Pink
Reliability Incorporated reported a significant revenue decline in Q2 2025, offset by improved gross margins and positive operating cash flow, amidst ongoing legal disputes.
OTC.Pink
Reliability Inc. experienced a decrease in revenue for the first quarter of 2025, while continuing efforts to recover funds from the Vivos Group.
OTC.Pink
Reliability Inc. saw a revenue increase in the third quarter of 2024 compared to the same period last year, driven by its Employer of Record segment, but still reported a net loss.
OTC.Pink
Reliability Inc. saw a revenue increase in the second quarter of 2024 compared to the same period last year, while continuing to navigate ongoing legal challenges.
OTC.Pink
Reliability Inc. saw a marginal increase in revenue for the first quarter of 2024, while continuing to navigate legal challenges and related party debt issues.